3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 1
4
Phase 1/2
2
Phase 2/3
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Ovarian Neoplasms
4
Fallopian Tube Neoplasms
4
Sarcoma
1
Ovarian Cancer Recurrent
1
Cystadenocarcinoma, Serous
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Interventions
Doxorubicin
3
Radiotherapy
2
Drug Therapy
2
pirarubicin
1
pazopanib
1
liposomal doxorubicin
1
capmatinib
1
anlotinib
1
Triptorelin Pamoate
1
Trabectedin
1
Radiation
1
Methotrexate
1
Ifosfamide
1
Fatty Acids, Omega-3
1
Cisplatin
1
Atorvastatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Sarcoma
×
liposomal doxorubicin
×
Clear all
NCT03342300
2020-05-19
PDVPSTS
Peking University People's Hospital
Phase 2/3
Withdrawn